↓ Skip to main content

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives

Overview of attention for article published in Frontiers in oncology, August 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Published in
Frontiers in oncology, August 2021
DOI 10.3389/fonc.2021.733770
Pubmed ID
Authors

Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, Alessandro Pileri, Alba Guglielmo, Luca Tonella, Martina Sanlorenzo, Simone Ribero, Maria Teresa Fierro, Pietro Quaglino

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 27%
Student > Postgraduate 1 9%
Student > Doctoral Student 1 9%
Student > Master 1 9%
Unknown 5 45%
Readers by discipline Count As %
Medicine and Dentistry 2 18%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Computer Science 1 9%
Nursing and Health Professions 1 9%
Unknown 6 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2021.
All research outputs
#19,961,193
of 25,392,582 outputs
Outputs from Frontiers in oncology
#9,332
of 22,436 outputs
Outputs of similar age
#301,363
of 421,288 outputs
Outputs of similar age from Frontiers in oncology
#532
of 1,351 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,288 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,351 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.